良性攝護腺增生手術器材市場：依產品類型、最終用戶及地區分類

2026年良性前列腺增生（BPH）手術器械市場規模估計為229億美元，預計2033年將達到387億美元。預計2026年至2033年，該市場將以8.4%的複合年成長率成長。

良性攝護腺增生（BPH）是一種以攝護腺非癌性增大為特徵的疾病，常見於50歲以上的男性。根據2015年發表在《刺胳針》上的一項研究，全球有超過1億人患有BPH。 α受體阻斷劑和5α還原酶抑制劑（5ARI）等藥物、經尿道前列腺切除術（TURP）等外科手術以及植入、射頻消融術和雷射等微創手術是該疾病的主要治療選擇。由於手術和微創療法能夠提供永久性解決方案，預計在預測期內，良性前列腺腫瘤手術器械市場將顯著成長。

市場動態

對微創療法（例如植入、前列腺支架和雷射治療）日益成長的需求預計將成為該市場的主要驅動力。儘管植入進入良性前列腺增生 (BPH) 市場的時間較晚，但需求正在不斷成長。 NeoTract 公司於 2010 年在歐洲首次獲得 BPH植入核准。如此巨大的交易量表明，這些產品在短期內在美國和歐洲等已開發國家擁有巨大的市場機遇，長期來看，其市場前景廣闊。近年來，其他一些新治療方法，例如前列腺動脈栓塞術 (PAE)，也引起了人們的關注，預計在不久的將來，它們將在 BPH 的治療中廣泛應用。 PAE 等新治療方法的引入預計將進一步推動市場成長。此外，老年人口的不斷成長以及易患此病的人群，預計也將促進該市場的成長。根據美國國家人口與人口統計研究所的數據，預計到 2060 年，美國 65 歲及以上人口將從 2014 年的 4,600 萬人增加一倍以上，達到 9,800 萬人。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
• 本研究根據以下參數對全球良性前列腺增生 (BPH) 手術器材市場的主要參與者進行了分析：公司概況、財務績效、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
• 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
• 這份《全球良性前列腺增生外科醫療設備市場》報告旨在為業界的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過對良性前列腺增生手術器械市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 併購和投資
• 創業趨勢
• 流行病學
• 影響分析
• 監管趨勢
• 管道分析
• 技術進步
• 良性攝護腺增生症的管理框架

第4章 全球良性攝護腺增生外科器材市場：依產品類型分類，2021-2033年

• 電切鏡
• 射頻消融術裝置
• 泌尿系統雷射
• 攝護腺支架
• 植入
• 其他

第5章 全球良性攝護腺增生外科器材市場：依最終用戶分類，2021-2033年

• 醫院
• 門診手術中心

第6章 全球良性攝護腺增生外科器材市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
• 非洲
  • 中非
  • 南非
  • 北非
• 中東
  • GCC
  • 以色列
  • 其他中東國家

第7章 競爭情勢

• 熱圖分析
• 公司簡介
  • Olympus Corporation
  • Boston Scientific Corporation
  • KARL STORZ SE & Co. KG
  • Medifocus Inc.
  • NxThera, Inc.
  • ProArc Medical
  • Lisa Laser Products OHG
  • Richard Wolf Gmbh

第8章

• 參考
• 調查方法

Benign Prostatic Hyperplasia Surgical Devices Market is estimated to be valued at USD 22.9 Bn in 2026 and is expected to reach USD 38.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2033.

Benign prostatic hyperplasia (BPH) is a medical condition, which is characterized by non-cancerous enlargement of prostate and it generally affects men aged more than 50 years. According to the study published in The Lancet in 2015, more than 100 million people were suffering from benign prostatic hyperplasia (BPH) globally. Drugs such as Alpha- blockers and 5a-Reductase inhibitors (5ARIs), surgery such as transurethral resection of the prostate (TURP), and minimally invasive surgeries such as implants, radiofrequency ablation, and lasers are the primary treatment options available for the disease. As surgery and minimally invasive therapy offers permanent solution, the benign prostatic surgical devices market is expected to grow significantly during the forecast period.

Market Dynamics

Increasing demand for minimally invasive therapy such as implants, prostatic stents and laser therapy are expected to be primary driving force for this market. Although implant has entered very late in benign prostatic hyperplasia market, its demand is increasing. NeoTract, Inc. received the approval for first implant for benign prostatic hyperplasia in 2010 and 2013 in Europe and U.S. respectively. This huge transaction value underlines the market opportunity for such products in developed economies such as the U.S. and European economies in short-term period and globally in long-term period. Other novel treatment options such as prostatic artery embolization (PAE) has also gained traction in recent years and its application for benign prostatic hyperplasia treatment is expected to get streamlined in near future. The introduction of novel treatments options such as PAE is expected to lead to further growth in the market. Moreover, increasing aging population, which is more prone to the disease is expected to support the growth of this market. According to Population Reference Bureau, the number of American people aged 65 years and above is expected to more than double from 46 million in 2014 to 98 million by 2060.

Key features of the study

• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global benign prostatic hyperplasia surgical devices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Olympus Corporation, Boston Scientific Corporation, Medifocus Inc., KARL STORZ SE & Co. KG, NxThera, Inc., ProArc Medical, Lisa Laser Products OHG, and Richard Wolf Gmbh
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global benign prostatic hyperplasia surgical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the benign prostatic hyperplasia surgical devices market

Market Segmentation

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Resectoscopes
  • Radiofrequency Ablation Devices
  • Urology Lasers
  • Prostatic Stents
  • Implants
  • Others
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals
  • Ambulatory Surgery Centers
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Key Players
  • Olympus Corporation
  • Boston Scientific Corporation
  • Medifocus Inc.
  • KARL STORZ SE & Co. KG
  • NxThera, Inc.
  • ProArc Medical
  • Lisa Laser Products OHG
  • Richard Wolf Gmbh.

Table of Contents

1. Research Objective and assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Mergers & Acquisitions and Investments
• Start-Up Presence
• Epidemiology
• Impact Analysis
• Regulatory Scenario
• Pipeline Analysis
• Technology Evolution
• Benign Prostatic Hyperplasia Management Framework

4. Global Benign Prostatic Hyperplasia Surgical Devices Market, By Product Type, 2021-2033 (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Resectoscopes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Radiofrequency Ablation Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Urology Lasers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Prostatic Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Implants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Benign Prostatic Hyperplasia Surgical Devices Market, By End User, 2021-2033 (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Benign Prostatic Hyperplasia Surgical Devices Market, By Region, 2021-2033 (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2022-2033
• North America
  • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
  • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
  • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
  • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
  • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
  • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
  • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
• Latin America
  • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
  • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
  • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
    • Brazil
    • Mexico
    • Rest of Latin America
• Africa
  • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
  • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
  • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
    • Central Africa
    • South Africa
    • North Africa
• Middle East
  • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
  • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
  • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East

7. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Olympus Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • KARL STORZ SE & Co. KG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medifocus Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NxThera, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ProArc Medical
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lisa Laser Products OHG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Richard Wolf Gmbh
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

• References
• Research Methodology
• About us and Sales Contact